This inventor holds 10 USPTO granted patents and 4 published patent applications and 2 EPO patents. Top assignees: Cancer Research Technology Limited, Cancer Research Campaign Technology Limited, Arquer Diagnostic Limited. Active years: 2000-2022.
Company Filing History:
5 out of 268 
3 out of 62 
1 out of 1 Years Active: 2000-2022
Title: The Innovative Contributions of Ronald Alfred Laskey
Introduction
Ronald Alfred Laskey is a prominent inventor based in Cambridge, GB. He has made significant contributions to the field of diagnostics, particularly in cancer research. With a total of 10 patents to his name, Laskey's work has had a profound impact on medical technology and diagnostics.
Latest Patents
Laskey's latest patents include innovative methods and kits for detecting the presence of Mcm5 in a subject. The method involves preparing a sample from the subject by exposing it to a lysis buffer and performing an assay to determine the concentration of Mcm5. This is achieved by exposing the sample to a first monoclonal antibody and/or a second monoclonal antibody, measuring the amount of Mcm5 that binds to these antibodies. Additionally, he has developed a diagnostic/prognostic assay for prostate cancer, which includes kits used in the assay.
Career Highlights
Throughout his career, Laskey has worked with notable organizations such as Cancer Research Technology Limited and Cancer Research Campaign Technology Limited. His work has been instrumental in advancing cancer diagnostics and improving patient outcomes.
Collaborations
Laskey has collaborated with esteemed colleagues, including Nicholas Coleman and Gareth Paul Williams. These partnerships have further enhanced the quality and impact of his research.
Conclusion
Ronald Alfred Laskey's innovative contributions to cancer diagnostics exemplify the importance of research and development in the medical field. His patents and collaborations continue to influence advancements in healthcare technology.